Screener

Net loss

Name: Vir Biotechnology, Inc. Net loss by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Vir Biotechnology, Inc.·Business Segments·1 segment·Rolls up to Net Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Business Segments	-$120.97M	-$110.96M	-$163.14M	-$42.92M	-$125.7M	$80.08M
Total	-$120.97M	-$110.96M	-$163.14M	-$42.92M	-$125.7M	$80.08M

Business SegmentsView metric